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Iliac fixation inhibits migration of both suprarenal
and infrarenal aortic endografts
Peyman Benharash, MD, Jason T. Lee, MD, Oscar J. Abilez, MD, Tami Crabtree, MS,
Daniel A. Bloch, PhD, and Christopher K. Zarins, MD, Stanford, Calif
Objective: To evaluate the role of iliac fixation in preventing migration of suprarenal and infrarenal aortic endografts.
Methods: Quantitative image analysis was performed in 92 patients with infrarenal aortic aneurysms (76 men and 16
women) treated with suprarenal (n  36) or infrarenal (n  56) aortic endografts from 2000 to 2004. The longitudinal
centerline distance from the superior mesenteric artery to the top of the stent graft was measured on preoperative,
postimplantation, and 1-year three-dimensional computed tomographic scans, with movement more than 5 mm
considered to be significant. Aortic diameters were measured perpendicular to the centerline axis. Proximal and distal
fixation lengths were defined as the lengths of stent-graft apposition to the aortic neck and the common iliac arteries,
respectively.
Results: There were no significant differences in age, comorbidities, or preoperative aneurysm size (suprarenal, 6.0 cm;
infrarenal, 5.7 cm) between the suprarenal and infrarenal groups. However, the suprarenal group had less favorable aortic
necks with a shorter length (13 vs 25mm; P< .0001), a larger diameter (27 vs 24mm; P< .0001), and greater angulation
(19° vs 11°; P  .007) compared with the infrarenal group. The proximal aortic fixation length was greater in the
suprarenal than in the infrarenal group (22 vs 16 mm; P < .0001), with the top of the device closer to the superior
mesenteric artery (8 vs 21 mm; P < .0001) as a result of the 15-mm uncovered suprarenal stent. There was no difference
in iliac fixation length between the suprarenal and infrarenal groups (26 vs 25 mm; P .8). Longitudinal centerline stent
graft movement at 1 year was similar in the suprarenal and infrarenal groups (4.3  4.4 mm vs 4.8  4.3 mm; P  .6).
Patients with longitudinal centerline movement of more than 5 mm at 1 year or clinical evidence of migration at any time
during the follow-up period comprised the respective migrator groups. Suprarenal migrators had a shorter iliac fixation
length (17 vs 29 mm; P  .006) and a similar aortic fixation length (23 vs 22 mm; P > .999) compared with suprarenal
nonmigrators. Infrarenal migrators had a shorter iliac fixation length (18 vs 30 mm; P < .0001) and a similar aortic
fixation length (14 vs 17 mm; P .1) compared with infrarenal nonmigrators. Nonmigrators had closer device proximity
to the hypogastric arteries in both the suprarenal (7 vs 17 mm; P .009) and infrarenal (8 vs 24 mm; P< .0001) groups.
No migration occurred in either group in patients with good iliac fixation. Multivariate logistic regression analysis
revealed that iliac fixation, as evidenced by iliac fixation length (P  .004) and the device to hypogastric artery distance
(P  .002), was a significant independent predictor of migration, whereas suprarenal or infrarenal treatment was not a
significant predictor of migration. During a clinical follow-up period of 45  22 months (range, 12-70 months), there
have been no aneurysm ruptures, abdominal aortic aneurysm–related deaths, or surgical conversions in either group.
Conclusions:Distal iliac fixation is important in preventing migration of both suprarenal and infrarenal aortic endografts
that have longitudinal columnar support. Secure iliac fixation minimizes the risk of migration despite suboptimal
proximal aortic neck anatomy. Extension of both iliac limbs to cover the entire common iliac artery to the iliac bifurcation
seems to prevent endograft migration. (J Vasc Surg 2007;45:250-7.)Endovascular repair of infrarenal aortic aneurysms
(EVAR) has been shown to have favorable outcomes when
compared with open aneurysm repair.1-4 However, there
are ongoing concerns regarding the long-term durability of
EVAR due to device-related failure modes such as migra-
tion, endoleaks, aneurysm enlargement, and stent frac-
tures.5
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250The migration and positional stability of aortic stent
grafts have been studied extensively,5-10 with emphasis on
patient selection; preoperative measurement of aortic neck
diameter, length, angulation, thrombus, and calcification;
intraoperative considerations of device sizing and position-
ing; and postoperative measurement of proximal fixation
length.11,12 A great deal of attention has been focused on
proximal endograft fixation with currently available devices
using a variety of fixation mechanisms, including infrarenal
and/or suprarenal fixation with radial force, with or with-
out penetrating hooks or barbs. However, device migration
continues to be an issue for all currently available devices.13-15
This may be explained, in part, by the failure of most studies
to consider the role of distal iliac fixation in maintaining the
positional stability of stent grafts.6,7,11,12,16,17
Heikkinen et al18 showed that the migration of an
infrarenal endograft with longitudinal columnar support
was closely related to the adequacy of iliac fixation. No
stent-graft migration occurred in patients who had good
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aortic fixation. Multivariate analysis identified iliac fixation
as the most important predictor of stent-graft migration or
stability over a 2-year observation period. The single most
important factor in preventing migration was close proximity
of the distal end of the endograft to the origin of the
internal iliac artery. This suggested that the bifurcation
of the iliac arteries may provide a point of positional stabil-
ity. The purpose of this study was to determine whether
iliac fixation is uniquely important to a single stent-graft
system or whether it may have broader implications for
other infrarenal aortic endovascular devices. To this end,
we have compared two modular stent graft systems that
both rely on radial and frictional fixation forces and longi-
tudinal columnar support without penetrating hooks or
barbs. One has a suprarenal fixation stent, whereas the
other is an infrarenal device. Sequential quantitative image
analysis was used to determine proximal and distal fixation
lengths and endograft positional stability at 1 year.
METHODS
Patients with infrarenal abdominal aortic aneurysms
who were treated with EVAR at Stanford University Med-
ical Center and enrolled in a prospective clinical and image-
based follow-up protocol were considered for this study.
Informed consent was obtained from each patient before
surgery, and all patient follow-up protocols, including im-
aging protocols, were approved by the institutional review
board. A total of 367 patients were treated with either a
suprarenal endograft with longitudinal columnar support
(Talent stent graft; Medtronic Vascular, Santa Rosa, Calif)
or an infrarenal endograft with longitudinal columnar sup-
port (AneuRx stent graft; Medtronic Vascular) from 2000
to 2004. All patients with preoperative and sequential
postoperative imaging studies performed at Stanford Uni-
versity Medical Center with online data sets available for
workstation review and three-dimensional image analysis
were selected for this study. A total of 92 patients met the
inclusion criteria for this study: 36 patients treated with the
suprarenal device and 56 patients treated with the infrarenal
device.
Preoperative and postoperative spiral computed tomo-
graphic (CT) scans and 1-year follow-up spiral CT scans or
magnetic resonance imaging studies were evaluated in each
patient by using quantitative three-dimensional image anal-
ysis. Three-dimensional reconstructions and volume render-
ing were performed on a TeraRecon workstation (TeraRecon
Inc, San Mateo, Calif) with maximum-intensity projection,
centerline, and orthonormal views, thus allowing for mea-
surement of angles and curvilinear distances. All reported
diameters were measured perpendicular to the centerline
axis, and the reported lengths were curvilinear distances
measured along the centerline of vessels. Measurements
were performed on images obtained before (range, 1-35
days), immediately after (range, 1-4 days), and 1 year after
(range, 11-14 months) the endovascular procedure. All
quantitative imaging measurements were obtained by a
single investigator with special training in three-dimensionalimage analysis whowas not involved with the clinical care of
the patients and was blinded to the clinical outcomes of the
patients.
The origin of the superior mesenteric artery (SMA) was
used as the reference point to determine the luminal cen-
terline distance to the proximal portion of the stent graft on
postimplantation and 1-year CT scans. An increase in lon-
gitudinal centerline distance more than 5 mm at 1 year was
considered to be significant. Proximal and distal (iliac)
fixation lengths were defined as the length of the stent graft
that was in full apposition to the aorta and common iliac
arteries, respectively (Fig 1, B). The proximal fixation
length for suprarenal devices included the suprarenal bare
stent and the infrarenal covered apposition zones. Infrare-
nal neck length was defined as the length of aorta between
the lowermost renal artery and the beginning of the most
proximal portion of the aneurysm. The angle between the
suprarenal and infrarenal aorta was determined by using
centerline measurements (Fig 1, A).
Complete and current clinical follow-up data were
available on all patients in the prospectively maintained
clinical database. Patient characteristics and comorbidities
were recorded along with follow-up information, compli-
Fig 1. A,Measurement of preoperative aneurysm characteristics.
B, Depiction of poststent image measurements.cations, secondary procedures, and long-term outcomes.
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were assigned to the suprarenal and infrarenal groups,
respectively. For comparison, the cohort was further di-
vided into the migrator and nonmigrator groups for both
devices. Patients were placed in the migrator group if there
was an increase in centerline distance from the origin of the
SMA to the proximal edge of the stent graft of more than
5mm at 1 year or if at any time during the clinical follow-up
period there was radiographic evidence of migration more
than 10 mm or if a secondary procedure (extender cuff
placement or proximal neck balloon dilation/stenting) was
performed.
Baseline demographics for the patients are expressed as
the mean SD for continuous variables and as percentages
of the cohort for binary variables. Statistical analysis was
performed by using SAS version 9.1 (SAS Institute, Cary,
NC). Comparisons between groups were made by using
the Student t test or Wilcoxon rank sum test for continuous
variables and the 2 or Fisher exact test for binary variables,
as appropriate. Predictors of migration were analyzed by
using multivariate logistic regression. P values .05 were
considered significant.
RESULTS
Among the 92 patients included in this study, 36 (39%)
were treated with the suprarenal device, and 56 (61%) were
treated with the infrarenal device. The demographics of the
patients in the suprarenal and infrarenal group are shown in
Table I. The suprarenal and infrarenal groups did not differ
significantly in age, sex distribution, or comorbidities. Pre-
operative aneurysm size was similar in the two groups
(suprarenal, 6.0  0.1 cm; infrarenal, 5.7  0.1 cm; P 
.2). However, the suprarenal group had less favorable aortic
necks, as evidenced by shorter neck length (13 vs 25 mm;
P  .0001), larger neck diameter (27 vs 24 mm; P 
.0001), and greater neck angulation (19° vs 11°; P .007)
compared with the infrarenal group. Despite a shorter
aortic neck length, the suprarenal group had a longer
Table I. Demographic data and comorbidities in patients
with the suprarenal and infrarenal devices
Variable
Suprarenal
fixation
(n  36)
Infrarenal
fixation
(n  56)
P
value
Age, y (mean  SD) 76  6 73  7 .09
Female (%) 22% 14% .3
Obesity (%) 25% 29% .7
Hypertension (%) 75% 71% .7
Smoking (%) 86% 77% .3
Chronic obstructive
pulmonary disease (%) 33% 25% .4
Coronary artery disease (%) 58% 38% .05
Congestive heart failure (%) 19% 14% .5
Cancer (%) 36% 29% .4
Diabetes (%) 28% 21% .5
Chronic renal insufficiency,
creatinine 1.5 mg/dL (%) 11% 16% .5proximal fixation length (22 vs 16mm; P .0001), and thetop of the device was closer to the SMA (8 vs 21 mm; P 
.0001) as a result of the 15-mm-long uncovered suprarenal
stent (Table II).
Longitudinal (caudal) centerline movement of the de-
vice at 1 year was detected in both the suprarenal and
infrarenal groups. There was no difference in the mean
caudal centerline movement distance between the suprare-
nal (4.3  4.4 mm) and infrarenal (4.8  4.3; P  .6)
groups. Ten patients (28%) in the suprarenal group and 20
patients (36%) in the infrarenal group had caudal move-
ment of more than 5 mm at 1 year or evidence of clinical
migration during the follow-up period and comprised the
respective migrator groups. There was no significant differ-
ence in mean follow-up time between the migrator and
nonmigrator groups (P .6). In the suprarenal cohort, the
migrator and nonmigrator groups did not differ signifi-
cantly in preoperative aneurysm diameter, infrarenal neck
diameter, proximal fixation length, or comorbidities. There
was no difference in proximal fixation length between the
migrator and nonmigrator groups (23 vs 22 mm; P 
.999). However, the migrator group had a significantly
shorter iliac fixation length (17  6 mm) compared with
the nonmigrator group (29  11 mm; P  .006). In
addition, themigrator group had a twofold greater distance
between the end of the iliac limb and the hypogastric artery
(17  9 mm) compared with the nonmigrator group (7 
9 mm; P  .009; Table III).
In patients with infrarenal fixation, the migrator and
nonmigrator groups were similar in preoperative aneurysm
Table II. Aneurysm characteristics for patients with
suprarenal versus infrarenal fixation
Variable
Suprarenal
fixation
(n  36)
Infrarenal
fixation
(n  56)
P
value
Preoperative aneurysm
diameter (mm) 60  11 57  11 .2
Preoperative infrarenal
neck diameter (mm) 27  3 24  2 .0001
Preoperative neck length
(mm) 13  8 25  9 .0001
Proximal fixation length
(mm) 22  8 16  6 .0001
Angulation, suprarenal to
infrarenal aorta (°) 19  10 11  10 .007
SMA to top of stent graft
(mm) 8  7 21  8 .0001
Iliac fixation length (mm)* 26  11 25  10 .8
Device to hypogastric
artery distance (mm)* 9.5  10 14  11 .06
Migration distance at 1 y
(mm) 4.3  4.4 4.8  4.3 .6
Type I endoleak (%) 6% 9% .7
Type II endoleak (%) 31% 18% .2
Secondary interventions at
1 y (%) 17% 23% .4
Data are mean  SD or percentages, as indicated.
SMA, Superior mesenteric artery.
*The average value of the right and left sides is given.diameter (60 vs 55 mm; P  .07) and infrarenal neck
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in proximal fixation length between the migrator and non-
migrator groups (14 vs 17 mm; P  .1). However, the
migrator group had a significantly shorter iliac fixation
length (18  7 mm) compared with the nonmigrator
group (30  9 mm; P  .001). In addition, the migrator
group had a threefold greater distance from the iliac limb to
the hypogastric artery (24  10 mm) compared with the
nonmigrator group (8  5 mm; P  .001; Table III).
Examples of migration in relation to iliac fixation are
shown in Figure 2. During a mean clinical follow-up time of
45  22 months (range, 12-70 months), there have been
no aneurysm ruptures, no abdominal aortic aneurysm–related
deaths, and no surgical conversions to open surgical repair.
Type I endoleaks have been documented in 6% of patients
with a suprarenal device and 9% of patients with an infrare-
nal device at some time during the study period, with no
difference between the groups (P  .7). Type II endoleaks
have been documented in 31% of patients in the suprarenal
group and 18% in the infrarenal group (P .2). There have
been no major adverse clinical events related to migration
or the endovascular device in either group. During the
follow-up period, secondary treatments have been per-
formed in 6 (17%) of 36 patients with suprarenal and 10
(23%) of 56 patients with infrarenal devices, with no differ-
ence between groups (P  .4). Secondary treatments in-
cluded interventions to treat migration and type I en-
doleaks, extender modules to increase proximal or distal
fixation without migration or endoleak, and coil emboliza-
tion or aneurysm sac injections for type II endoleaks. The
most common secondary procedure was placement of
modular iliac extender cuffs to the level of the hypogastric
artery (42% of secondary procedures), with no evidence of
subsequent stent graft movement in either the suprarenal
or infrarenal group.
Multivariate logistic regression models were used to
identify predictors of migration and their respective predic-
tive values (Table IV). Surprisingly, neither proximal fixa-
Table III. Preoperative and postoperative imaging charac
greater than 5 mm at 1 year
Variable
Suprarena
Migrator
(n  10)
N
Preoperative aneurysm diameter (mm) 60  9
Preoperative infrarenal neck diameter (mm) 26  2
Preoperative infrarenal neck length (mm) 10  9
Proximal fixation length (mm) 23  9
Angulation, suprarenal to infrarenal aorta (°) 31  22
Iliac fixation length (mm)* 17  6
Device to hypogastric artery distance (mm)* 17  9
Migration distance at 1 y (mm) 10  4
Endoleak rate (%) 40%
Secondary intervention rate (%) 30%
Data are mean  SD or percentages, as indicated.
*The average value of the right and left sides is given.tion length nor device type (suprarenal vs infrarenal) was asignificant predictor of migration in the presence of other
variables in the model. Conversely, iliac fixation length (P 
.004) and the device to hypogastric artery distance (P 
.002) were highly significant predictors of stent-graft mi-
gration. The odds ratio for iliac fixation length was 0.589,
thus indicating that for each millimeter increase in iliac
fixation length, the odds of migration are reduced by 41% if
all other factors in the model are held constant. The odds
ratio for the device to hypogastric distance was 1.533, thus
indicating that for each millimeter increase in distance from
the hypogastric artery, the odds of migration increase by
53% if all other factors are held constant. The odds ratios
were similar when the suprarenal and infrarenal groups
were analyzed individually. Other factors, such as age, sex,
medical comorbidities, maximum aneurysm diameter, pre-
operative neck angulation, and neck diameter or neck
length, did not have a significant effect on risk of migration.
DISCUSSION
The importance of proximal aortic fixation in maintain-
ing the positional stability of aortic endografts is well rec-
ognized.6-12 An analysis of migration among 1119 patients
enrolled in the multicenter AneuRx clinical trial from 1996
to 1999 showed that the proximal stent-graft fixation
length was significantly shorter in patients with migration
compared with patients without migration (16 vs 23 mm;
P  .005).11 Multivariate analysis of AneuRx Core Labo-
ratory CT imaging data revealed that proximal fixation
length (P  .005) and renal to stent graft distance (P 
.001) were significant predictors of migration. There was
significant variation in migration rates among clinical sites
(P  .001), ranging from 0% to 30%, and the differences
were not well explained by differences in proximal fixation
lengths among sites or the use of proximal extender cuffs at
the time of implantation.11 There was no information on
iliac fixation because this was not evaluated by the Core
Laboratory, and the only data related to iliac fixation were
a determination of whether an iliac type I endoleak was
ics in relation to longitudinal centerline movement
tion (n  36) Infrarenal fixation (n  56)
grator
26) P value
Migrator
(n  20)
Nonmigrator
(n  36) P value
12 .9 60  10 55  11 .07
3 .3 25  2 23  2 .07
8 .2 23  10 26  9 .06
7 .999 14  4 17  6 .1
11 .05 10  10 12  10 .7
11 .006 18  7 30  9 .0001
9 .009 24  10 8  5 .0001
2 .0001 10  3 2  2 .0001
% .8 40% 19% .1
% .3 55% 6% .0001terist
l fixa
onmi
(n 
60 
27 
14 
22 
14 
29 
7 
2 
35
12present. In fact, the role of distal iliac fixation has only
*The average value of the right and left sides is given.
no subsequent migration.
JOURNAL OF VASCULAR SURGERY
February 2007254 Benharash et alrecently been identified as an important factor in prevent-
ing stent-graft migration. Despite numerous clinical studies
seeking to identify factors that may contribute to migra-
tion, iliac fixation was not taken into consideration until the
report by Heikkinen et al18 in 2006. Among 173 patients
treated with the AneuRx stent graft from 1996 to 2003,
Heikkinen et al found that 17 patients (10%) had migration
during a mean follow-up period of 23 months and that all
17 patients had evidence of suboptimal iliac fixation on the
postimplantation CT scan. Proximal and distal fixation
were classified as good, bad, or intermediate according to
CT measurement of fixation lengths. Good iliac fixation
was defined as an iliac fixation length of at least 25 mm,
with the distal end of the stent graft within 10 mm of the
iliac bifurcation. Patients with good iliac fixation experi-
enced no stent graft migration even in the face of bad or
intermediate proximal aortic fixation. Migration occurred
l stent graft with good iliac fixation and no migration.
as treated with iliac extender cuff placement, with no
al and distal fixation and no migration. D, Suprarenal
tion was treated with iliac extender cuff placement, withTable IV. Multivariate logistic regression for migration
greater than 5 mm
Factor Estimate
Standard
error
P
value
Odds
ratio
Angulation (°) 0.07 0.05 .2 1.185
Infrarenal neck length (mm) 0.05 0.07 .5 0.953
Infrarenal neck diameter
(mm) 0.14 0.26 .6 0.874
Proximal fixation length
(mm) 0.11 0.09 .2 0.893
Maximum preoperative
aneurysm diameter (mm) 0.04 0.07 .5 1.046
Iliac fixation length (mm)* 0.53 0.18 .004 0.589
Distance to hypogastric
artery (mm)* 0.43 0.14 .002 1.533
Suprarenal fixation (vs
infrarenal) 0.16 0.01 .9 0.853Fig 2. Examples of good and bad iliac fixation. A, Infrarena
B, Infrarenal stent graft with poor iliac fixation; migration w
further migration. C, Suprarenal stent graft with good proxim
stent graft with good proximal and poor distal fixation; migraonly in patients with bad or intermediate iliac fixation, and
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fixation. Both proximal and distal fixation were indepen-
dent predictors of migration, and the proximity of the distal
end of the stent graft to the iliac bifurcation seemed to be
the single most important factor in preventing migration.18
In this study, we sought to determine whether iliac
fixation also played a role in preventing migration of en-
dografts with suprarenal stent fixation and longitudinal
columnar support. We used a more advanced quantitative
image-analysis methodology (TeraRecon) to evaluate pre-
implantation and postimplantation CT scans of both supra-
renal and infrarenal devices. Measurements were taken by a
single observer, who was blinded to the clinical outcomes
of the patients. Only patients with imaging studies per-
formed at Stanford Medical Center and available in the
hospital’s electronic image storage system were included in
this analysis. Because migration may be a time-dependent
event, we sought to eliminate time as a variable in this study
by evaluating stent-graft positional change at the same
1-year postprocedure time interval in all patients. Further-
more, we measured aortic and iliac fixation lengths directly
on postimplantation CT scan curved planar reformations of
the aorta and each iliac artery. This eliminated potential
inaccuracies that may arise from calculating the iliac fixation
lengths by subtracting the postprocedure distance to the
hypogastric artery from the preoperative iliac length and
proximal fixation lengths by subtracting the renal to stent
graft distance from the preoperative aortic neck length
measurements.18 We used the same direct-measurement
technique to determine the postoperative distance from the
stent graft to the hypogastric artery. To address the ques-
tion of whether iliac artery length changes significantly as a
result of endovascular manipulation and straightening by
the stiff guidewire and stent graft, we measured the iliac
artery length before and after endovascular treatment and
found no significant change in iliac artery length. Themean
preoperative iliac artery length was 39 mm, and the mean
postoperative iliac artery length was 38 mm (P  .5).
We found that both suprarenal and infrarenal stent
grafts may rely to a significant extent on iliac fixation to
maintain the positional stability of the device. Both the iliac
fixation length and the proximity of the stent graft to the
iliac bifurcation were associated with lower rates of longi-
tudinal displacement of the stent graft at 1 year. Patients
who experienced movement more than 5 mm in both the
suprarenal and infrarenal groups had significantly shorter
iliac fixation lengths and significantly greater distances to
the iliac bifurcation, thus highlighting the importance of
iliac fixation in preventing migration.
Although there was no difference in mean longitudinal
centerline movement at 1 year between the suprarenal and
infrarenal groups, a significant number of patients in both
groups (28% in the suprarenal and 36% in the infrarenal
group) exceeded the 5-mmmovement threshold for migra-
tion in this study. Whereas most clinical reports of migra-
tion have used a greater than 10-mm movement criterion
to define migration,19-21 we chose to use a threshold of 5
mm of longitudinal movement in order to be able to moreprecisely determine the relationship between iliac fixation
and endograft positional stability. The clinical significance
of this degree of longitudinal centerline positional change is
uncertain, and this measure may not be comparable to the
more commonly used method of axial measurement of
endograft position to evaluate migration. In cases of sub-
stantial aortic neck and stent graft angulation, significant
changes in longitudinal centerline position may result in
little or no axial stent-graft displacement. We found no
clinical adverse events associated with greater than 5 mm of
centerline movement, although many patients underwent
secondary procedures as a result of or related to this move-
ment. With a greater than 10-mm centerline movement
threshold to define migration, there was no significant
difference in migration rates between the suprarenal group
(3/36; 8%) and infrarenal group (6/56; 11%).
Our findings are remarkable in that stent-graft migra-
tion occurred only in patients with poor iliac fixation.
Despite the inclusion of patients with short, angulated, and
large-diameter necks, no patient with good iliac fixation
experienced migration even if the proximal fixation length
was suboptimal. Therefore, secure iliac fixation, as docu-
mented by a long iliac fixation length and close proximity to
the hypogastric arteries, prevented migration in the supra-
renal group despite adverse neck anatomy. Similarly, there
was no migration in infrarenal devices with good iliac
fixation. These findings are similar to Heikkinen and col-
leages’ observations18 in a larger group of patients treated
with the AneuRx device and suggest that longitudinal
columnar support may be important in maintaining posi-
tional stability and preventing migration of both the Talent
suprarenal and the AneuRx infrarenal devices. A notable
difference between this study and that of Heikkinen et al is
that proximal fixation length was not found to be a signif-
icant factor in migration. This does not discount the im-
portance of proximal fixation and is likely due to the small
number of patients and the fact that the multivariate anal-
ysis included both suprarenal and infrarenal devices, which
have large differences in proximal fixation lengths as a result
of the bare metal suprarenal stent. Whether iliac fixation
plays an important role in devices with penetrating hook
fixation mechanisms remains to be determined.
No significant adverse events occurred as a result of
stent-graft movement; this may be because secondary pro-
cedures were performed in 17% of patients with the supra-
renal device and 23% of patients with the infrarenal device.
The most common secondary procedure was placement of
iliac extender modules to extend the stent graft to the level
of the hypogastric artery. There have been no instances of
subsequent stent-graft movement among patients who
have undergone secondary procedures to secure stent-graft
fixation. This suggests that the stent graft should be ex-
tended to the level of the hypogastric artery at the time of
the initial procedure in all patients, and this now is our
current clinical practice for both suprarenal and infrarenal
devices.
There are several limitations to our study. First, the
patients included in this study cohort represent a small
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tion and were selected on the basis of the availability of
sequential online images for analysis, including preopera-
tive imaging studies performed at Stanford. Patients re-
ferred to Stanford for evaluation and treatment of infrarenal
aneurysms usually have had contrast CT scans at their local
medical facility. Preoperative CT scans are repeated at
Stanford only if outside studies are inadequate or if there
are challenging anatomic features that require more de-
tailed analysis. Similarly, 1-year CT studies are often per-
formed at medical facilities closer to patients’ homes and
are performed at Stanford if there are particular concerns or
abnormalities. Thus, patients in this study may represent a
more difficult and challenging group of patients than those
found in usual clinical practice. Nonetheless, the data are
similar to and consistent with a larger study of all patients
treated at our institution with the infrarenal device with
imaging studies performed at outside institutions as well as
at Stanford.18 Second, the suprarenal and infrarenal patient
groups were not comparable with respect to preoperative
aortic neck anatomy; the suprarenal group had less favor-
able anatomy, with shorter neck lengths, larger neck diam-
eters, and increased neck angulation. This is due to the fact
that patients were usually selected for the suprarenal device
because they had large-diameter, angulated necks and did
not meet inclusion criteria for treatment with the commer-
cially available infrarenal device. These patients were en-
rolled in a physician-sponsored Investigational Device Ex-
emption with the suprarenal stent graft, which was available
in device diameters up to 36 mm. It is well known that
adverse neck anatomy increases the risk of migration, 6,10,12,17
and the suprarenal group was at a higher-than-expected risk
of migration as a result of adverse anatomic patient selec-
tion bias. Nonetheless, no migration occurred in this group
of patients with adverse anatomy if iliac fixation was secure.
Finally, the technical aspects of EVAR have evolved and
improved with time, and many of the infrarenal group were
treated before we fully appreciated the importance of iliac
fixation and incorporated routine extension to the iliac
bifurcation into our practice.
Although the iliac artery diameter is carefully evaluated
on preoperative imaging studies, iliac length is less often
considered in selecting patients for EVAR. This may in part
be because although axial CT images are usually adequate
to evaluate the infrarenal aortic neck and iliac diameters,
curvature and tortuosity of the iliac arteries makes iliac
length measurement unreliable and difficult. Accurate iliac
length measurements usually require three-dimensional re-
construction and centerline measurements, and these lengths
may change during the implantation procedure because of
the introduction of stiff guidewires and sheaths. Postim-
plantation determination of iliac fixation length is more
complex and thus is rarely assessed in current clinical prac-
tice. The easiest and most reliable measure of adequacy of
iliac fixation is the proximity of the distal end of the stent
graft to the hypogastric artery, and this measure should be
incorporated into routine postimplantation follow-up im-
age assessments. Although this study demonstrates theimportance of this measurement for the AneuRx and Talent
devices, the findings may not be generalizable to other
suprarenal and infrarenal devices, particularly those that
include other fixation mechanisms such as hooks and barbs.
Because migration may be seen with such devices, long-
term studies of these devices should include data on iliac
fixation to fully understand the dynamics of long-term
endograft stability.
CONCLUSION
Iliac fixation plays an important role in preventing the
migration of both suprarenal and infrarenal stent grafts
with longitudinal columnar support. Iliac fixation length
and the proximity of the stent graft to the iliac bifurcation
are independent predictors of migration. Extension of both
iliac limbs to the level of the iliac bifurcation seems to
prevent endograft migration. Secure iliac fixation seems to
minimize the risk of migration despite suboptimal proximal
neck anatomy. Further studies are needed to determine
whether iliac fixation is an important factor for endograft
devices with penetrating hook mechanisms.
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